Pamir Ozan, Chief Financial Officer of Niagen Bioscience, Inc. ($NAGE), made two open market purchases totaling about $46,000 in the last 365 days, with the most recent on November 14, 2025. These buys rank 3,137th among 4,983 individual insiders, below the average purchase of $1.5 million across 3.3 transactions. Ozan reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Niagen Bioscience, Inc. | $NAGE | Pamir Ozan | Chief Financial Officer | A | Employee Stock Options (right to buy) | 62131 | $0.00 | 62,131.0000 | 86,619,000 | 9999.99% | 0.07% |
| Nov. 14, 2025 | Niagen Bioscience, Inc. | $NAGE | Pamir Ozan | Chief Financial Officer | P | Common Stock | 4465 | $6.81 | 9,592.6020 | 86,619,000 | 87.08% | 0.01% |
| Nov. 14, 2025 | Niagen Bioscience, Inc. | $NAGE | Pamir Ozan | Chief Financial Officer | P | Common Stock | 2220 | $6.85 | 9,592.6020 | 86,619,000 | 30.12% | 0.00% |
| Feb. 12, 2025 | Niagen Bioscience, Inc. | $NAGE | Pamir Ozan | Chief Financial Officer | A | Employee Stock Options (right to buy) | 17230 | $0.00 | 17,230.0000 | 78,125,000 | 9999.99% | 0.02% |
| Nov. 22, 2024 | Niagen Bioscience, Inc. | $NAGE | Pamir Ozan | Chief Financial Officer | P | Common Stock | 2907 | $7.36 | 2,907.1970 | 77,768,000 | 9999.99% | 0.00% |
| Oct. 21, 2024 | Niagen Bioscience, Inc. | $NAGE | Pamir Ozan | Chief Financial Officer | A | Employee Stock Options (right to buy) | 146544 | $0.00 | 146,544.0000 | 77,768,000 | 9999.99% | 0.19% |